Guardion Health Sciences, Inc. (GHSI)

Recent filings

Guardion Health Sciences, Inc. Just Filed Its Quarterly Report: Loss per Common Shar... - May 12, 2022

Regulation FD - May 4, 2022

Other preliminary proxy statements - April 11, 2022

Guardion Health Sciences, Inc. Just Filed Its Annual Report: Loss per Common Shar... - March 31, 2022

Guardion Health Sciences, Inc. Announces Proposed Public Offering HOUSTON - Feb. 23, 2022

Guardion Health Sciences, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Feb. 22, 2022

Guardion Health Sciences, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Feb. 17, 2022

Entry into a Material Definitive - Jan. 28, 2022

Guardion Health Sciences, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Jan. 28, 2022

Notice of Delisting or Failure to Satisfy a Continue Listing Rule or - Jan. 27, 2022

Regulation FD - Jan. 12, 2022

Regulation FD - Jan. 10, 2022

Guardion Health Sciences To Wind Down Vectorvision Business Operations And Focus On Exploiting Vectorvision Intellectual Property - Dec. 27, 2021

Guardion Health Sciences Issues Letter To Shareholders - Dec. 17, 2021

Guardion Health Sciences, Inc. director was just granted 41,667 options - Dec. 15, 2021

Guardion Health Sciences, Inc. director just declared ownership of no shares of Guardion Health Sciences, Inc. - Dec. 15, 2021

Guardion Health Sciences Appoints Experienced Healthcare Executive Michaela Griggs To Its Board Of Directors HOUSTON - Dec. 9, 2021

Guardion Health - Dec. 8, 2021

Guardion Health Sciences, Inc. Just Filed Its Quarterly Report: Loss per Common Shar... - Nov. 10, 2021

Submission of Matters to a Vote of Security - Oct. 25, 2021

On October - Oct. 22, 2021

Termination of a Material Definitive - Sept. 23, 2021

Current report, items 8.01 and 9.01 - Sept. 10, 2021

Guardion Health Sciences, Inc.'s Chief Executive Officer was just granted 916,023 options - Sept. 1, 2021

Guardion Health Sciences, Inc.'s CEO and President just picked up 10,000 shares - Sept. 1, 2021

Guardion Health Sciences, Inc. director just picked up 5,000 shares - Aug. 31, 2021

Guardion Health Sciences, Inc. director just picked up 1,500 shares - Aug. 31, 2021

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - Aug. 25, 2021

Guardion Health Sciences, Inc. releases salary data. CEO sees compensation fall -91% - Aug. 25, 2021

Departure of Directors or Certain - Aug. 24, 2021

Guardion Health Sciences, Inc. director just picked up 10,000 shares - Aug. 23, 2021

Guardion Health Sciences, Inc. Just Filed Its Quarterly Report: Loss per Common Shar... - Aug. 16, 2021

Guardion Health Sciences Announces Financial Results - Aug. 16, 2021

Guardion Health Sciences: Those Charged With Governance - Aug. 10, 2021

Guardion Health Sciences: Those Charged With Governance - Aug. 10, 2021

Departure of Directors or Certain - Aug. 2, 2021

Guardion Health Sciences, Inc.'s Chief Accounting Officer just declared ownership of no shares of Guardion Health Sciences, Inc. - Aug. 2, 2021

Guardion Health Sciences, Inc. director was just granted 16,667 options - July 2, 2021

Guardion Health Sciences, Inc. director was just granted 16,667 options - July 2, 2021

Guardion Health Sciences, Inc. director was just granted 16,667 options - July 2, 2021

Guardion Health Sciences, Inc. director was just granted 16,667 options - July 2, 2021

Current report, items 7.01 and 9.01 - June 9, 2021

Guardion Health Sciences, Inc.'s Chief Commercial Officer just declared ownership of no shares of Guardion Health Sciences, Inc. - June 4, 2021

Guardion Health Sciences Broadens Clinical Nutrition Product Offerings By Closing Acquisition Of Activ Nutritional, Which Owns The Science Backed, Revenue-Generating Viactiv® Product Line, From Adare - June 4, 2021

Statement of changes in beneficial ownership of securities - June 4, 2021

Departure of Directors or Certain - May 24, 2021

Current report, items 1.01, 8.01, and 9.01 - May 21, 2021

Guardion Health Sciences Announces Financial Results - May 17, 2021

Quarterly report [Sections 13 or 15(d)] - May 17, 2021

Current report, items 8.01 and 9.01 - May 3, 2021

Securities to be offered to employees in employee benefit plans - April 7, 2021

Annual report [Section 13 and 15(d), not S-K Item 405] - March 26, 2021

Guardion Health Sciences Announces Financial Results - March 26, 2021

Guardion Health Sciences Regains Compliance With Nasdaq Minimum Bid Price Rule - March 16, 2021

Guardion Health Sciences Announces 1-For-6 Reverse Stock Split - March 1, 2021

Edward B. Grier III just provided an update on share ownership of Guardion Health Sciences, Inc. - Feb. 12, 2021

Entry into a Material Definitive - Jan. 28, 2021

Guardion Health Sciences, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Jan. 28, 2021

Nasdaq Grants Guardion Health Sciences An Extension To - Jan. 27, 2021

Entry into a Material Definitive - Jan. 8, 2021

Guardion Health Sciences, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Jan. 8, 2021

Guardion Health Sciences, Inc.'s Chief Executive Officer just declared owning 1,016,900 shares of Guardion Health Sciences, Inc. - Jan. 6, 2021

Guardion Health Sciences, Inc.'s CHIEF EXECUTIVE OFFICER just picked up 916,023 shares - Jan. 6, 2021

Guardion Health Sciences Appoints Seasoned Nutritional Products - Dec. 29, 2020

Sorry, no schedule available for this company

Guardion Health Sciences to Participate in Fireside Chat at the 34th Annual Roth Conference - March 11, 2022

Guardion Health Sciences, Inc. Announces Closing of $11 Million Public Offering - Feb. 23, 2022

Guardion Health Sciences, Inc. Announces Pricing of $11 Million Public Offering - Feb. 18, 2022

Guardion Health Sciences Launches New Online Store for Viactiv - Jan. 24, 2022

Guardion Health Sciences to Wind Down VectorVision Business Operations and Focus on Exploiting VectorVision Intellectual Property - Dec. 23, 2021

Guardion Health Sciences Issues Letter to Shareholders - Dec. 16, 2021

Guardion Health Sciences to Present at the Benzinga Global Small Cap Conference - Dec. 3, 2021

Guardion Health Sciences Announces Financial Results for the Three Months Ended September 30, 2021 - Nov. 10, 2021

Guardion Health Sciences to Present at the Benzinga Global Small Cap Conference - Oct. 25, 2021

Guardion Health Sciences Stockholders Urged to Vote Their Shares for October 22, 2021 Annual Meeting - Oct. 12, 2021

Guardion Health Sciences to Present at the LD Micro Main Event Conference - Oct. 5, 2021

Guardion Health Sciences to Present at the Benzinga Healthcare Small Cap Conference - Sept. 27, 2021

Guardion Health Sciences Announces Financial Results for the Three Months Ended June 30, 2021, including $1,000,000+ of Sales from Viactiv® Products in the First Month of Guardion’s Ownership - Aug. 16, 2021

Guardion Health Sciences to Exhibit at the American Society of Cataract and Refractive Surgery Annual Meeting - July 22, 2021

Guardion Health Sciences to Be Added to the Russell 3000 Index - June 14, 2021

Guardion Health Sciences Announces Appointment of Craig J. Sheehan as Chief Commercial Officer - June 3, 2021

Guardion Health Sciences Broadens Clinical Nutrition Product Offerings by Closing Acquisition of Activ Nutritional, which owns the Science Backed, Revenue-Generating Viactiv® Product Line, from Adare Pharmaceuticals - June 2, 2021

Guardion Health Sciences to Present at the LD Micro Virtual Invitational Conference on June 9, 2021 - June 2, 2021

Guardion Health Sciences to Acquire Activ Nutritional, LLC and Its Well-Known Viactiv® Brand of Products from Adare Pharmaceuticals, Inc. - May 18, 2021

Guardion Health Sciences Initiates Placebo-Controlled Clinical Trial Involving Proprietary GlaucoCetin® Product - May 3, 2021

 


Feedback